Expression and clinical significance of peripheral blood IL-9 and IL-22 in patients with endometrial cancer

Minerva Gastroenterol (Torino). 2024 Jun;70(2):245-247. doi: 10.23736/S2724-5985.23.03465-4. Epub 2023 Jun 20.

Authors

Xiaoxue Fu¹, Mengmeng Song¹, Rui Zhang², Fang Chen³

Affiliations

¹ Clinical College of Medicine, Department of Obstetrics and Gynecology, Weifang Medical University, Weifang, China.
² Department of Gynecology, Weifang People's Hospital, Weifang, China.
³ Department of Gynecology, Weifang People's Hospital, Weifang, China - lf201788@163.com.

PMID: 37338266
DOI: 10.23736/S2724-5985.23.03465-4

No abstract available

Publication types

Letter

MeSH terms

Aged
Biomarkers, Tumor / blood
Clinical Relevance
Endometrial Neoplasms* / blood
Female
Humans
Interleukin-22*
Interleukin-9* / blood
Interleukins* / blood
Middle Aged

Substances

Interleukins
Interleukin-22
Interleukin-9
IL9 protein, human
Biomarkers, Tumor